Guangdong Zhongsheng Pharmaceutical Co., Ltd.

SZSE:002317 Stock Report

Market Cap: CN¥11.0b

Guangdong Zhongsheng Pharmaceutical Management

Management criteria checks 3/4

Guangdong Zhongsheng Pharmaceutical's CEO is Yong Hong Chen, appointed in Jan 2011, has a tenure of 13.83 years. directly owns 1.62% of the company’s shares, worth CN¥178.54M. The average tenure of the management team and the board of directors is 5.9 years and 4.9 years respectively.

Key information

Yong Hong Chen

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure13.8yrs
CEO ownership1.6%
Management average tenure5.9yrs
Board average tenure4.9yrs

Recent management updates

Recent updates

We Think You Can Look Beyond Guangdong Zhongsheng Pharmaceutical's (SZSE:002317) Lackluster Earnings

Nov 04
We Think You Can Look Beyond Guangdong Zhongsheng Pharmaceutical's (SZSE:002317) Lackluster Earnings

Investor Optimism Abounds Guangdong Zhongsheng Pharmaceutical Co., Ltd. (SZSE:002317) But Growth Is Lacking

Oct 07
Investor Optimism Abounds Guangdong Zhongsheng Pharmaceutical Co., Ltd. (SZSE:002317) But Growth Is Lacking

These 4 Measures Indicate That Guangdong Zhongsheng Pharmaceutical (SZSE:002317) Is Using Debt Reasonably Well

Jul 12
These 4 Measures Indicate That Guangdong Zhongsheng Pharmaceutical (SZSE:002317) Is Using Debt Reasonably Well

Guangdong Zhongsheng Pharmaceutical Co., Ltd.'s (SZSE:002317) P/E Is On The Mark

Jun 18
Guangdong Zhongsheng Pharmaceutical Co., Ltd.'s (SZSE:002317) P/E Is On The Mark

Guangdong Zhongsheng Pharmaceutical (SZSE:002317) Has Affirmed Its Dividend Of CN¥0.20

May 20
Guangdong Zhongsheng Pharmaceutical (SZSE:002317) Has Affirmed Its Dividend Of CN¥0.20

We Think You Can Look Beyond Guangdong Zhongsheng Pharmaceutical's (SZSE:002317) Lackluster Earnings

Apr 29
We Think You Can Look Beyond Guangdong Zhongsheng Pharmaceutical's (SZSE:002317) Lackluster Earnings

Does Guangdong Zhongsheng Pharmaceutical (SZSE:002317) Have A Healthy Balance Sheet?

Mar 18
Does Guangdong Zhongsheng Pharmaceutical (SZSE:002317) Have A Healthy Balance Sheet?

Guangdong Zhongsheng Pharmaceutical Co., Ltd.'s (SZSE:002317) Shares Climb 29% But Its Business Is Yet to Catch Up

Feb 29
Guangdong Zhongsheng Pharmaceutical Co., Ltd.'s (SZSE:002317) Shares Climb 29% But Its Business Is Yet to Catch Up

CEO

Yong Hong Chen (53 yo)

13.8yrs

Tenure

CN¥498,700

Compensation

Mr. Yong Hong Chen serves as General Manager of Guangdong Huanan Pharmaceutical Group Co., Ltd. and Guangdong Zhongsheng Pharmaceutical Trade Co., Ltd. Mr. Chen serves as Executive Director of Guangdong Zh...


Leadership Team

NamePositionTenureCompensationOwnership
Yong Hong Chen
Chairman & President13.8yrsCN¥498.70k1.62%
CN¥ 178.5m
Yuchong Zhang
Vice Chairman & Senior VP7.9yrsCN¥311.50k10.95%
CN¥ 1.2b
Chun Hua Long
VP, CFO14.8yrsCN¥372.90k0.43%
CN¥ 47.0m
Xi Ping Zhao
VP & Director1.9yrsCN¥372.90k0.92%
CN¥ 101.2m
Shuang Liu
Vice President5.9yrsCN¥547.40kno data
Wei Yang
Board Secretary1.5yrsno datano data
Rikang Luo
Vice Presidentless than a yearno data0.0012%
CN¥ 130.1k

5.9yrs

Average Tenure

49yo

Average Age

Experienced Management: 002317's management team is seasoned and experienced (5.9 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Yong Hong Chen
Chairman & President13.8yrsCN¥498.70k1.62%
CN¥ 178.5m
Yuchong Zhang
Vice Chairman & Senior VP7.9yrsCN¥311.50k10.95%
CN¥ 1.2b
Chun Hua Long
VP, CFO10.8yrsCN¥372.90k0.43%
CN¥ 47.0m
Xi Ping Zhao
VP & Director1.9yrsCN¥372.90k0.92%
CN¥ 101.2m
Wen Tan
Non-Independent Director4.9yrsCN¥72.00kno data
Pengan Shan
Non-Independent Director7.9yrsCN¥72.00kno data
Ruichao Lin
Independent Director4.9yrsCN¥72.00kno data
Qinggong Wu
Independent Director4.9yrsCN¥72.00kno data
So Hyun Lee
Supervisor7.9yrsno datano data
Xiaorong Mou
Independent Director2.5yrsCN¥45.00kno data
Zhenyou Tan
Chairman of the Supervisory Board1.9yrsno datano data
Hougan Huang
Employee Supervisorless than a yearno datano data

4.9yrs

Average Tenure

53yo

Average Age

Experienced Board: 002317's board of directors are considered experienced (4.9 years average tenure).